Tag: Industry

3 Medical Instruments Stocks to Buy Amid Improving Industry Trends

The Medical Instruments industry has witnessed a significant transformation in the nature of business lately, leading to increased investment in R&D for the development of cutting-edge technologies. The dynamic nature of the healthcare crisis over the past two and a half years has further altered the industry landscape, putting robotic and remote medical services in the limelight. Despite the reopening of the economy, deteriorating international trade, with global inflationary pressure leading to an extremely tough situation related to raw material and labor cost as well as freight charges, has put the industry in a tight spot again. Further, industry watchers are still unable to gauge the magnitude of economic revival due to the emergence of new COVID strains in selective parts of the world from time to time.

The just-reported fourth-quarter result of a number of medical instrument companies confirmed a gradual rebound in their base businesses through the latter half of 2022. However, the industry-wide trend of staffing shortages and supply chain-related hazards are denting growth. Meanwhile, industry players like Edwards Lifesciences EW, IDEXX Laboratories IDXX and Hologic, Inc. HOLX have adapted well to changing consumer preferences and are still witnessing an uptrend in their stock prices.

Industry Description

The Zacks Medical – Instruments industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas. This FDA-regulated industry comprises an endless number of products, starting from transcatheter valves to orthopedic products to imaging equipment and robotics. Prior to the pandemic, the Medical Instruments space was advancing well in terms of R&D. Among the recent path-breaking inventions, bone growth stimulators, 3D mapping of CT scans, wireless brain sensors and human-brain pacemakers are worth mentioning. During the COVID-hit years, many non-COVID and non-emergency-line innovations were stuck or delayed. However, with the severity of the pandemic easing, the industry players are again more focused on strengthening their pipeline.

3 Trends Shaping the Future of the Medical Instruments Industry

Business Trend Disruption: Considering the ongoing macro-economic situation, the IMF came up with its January 2023 World Economic Outlook Update. The update noted that global growth might slightly slow down from 3.4{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in 2022, to 2.9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in 2023, then again rebound to 3.1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in 2024. IMF specifically addressed the ongoing tightening financial conditions in most regions, staffing shortages, Russia’s continued aggression, all of which have been weighing heavily on the medical instrument outlook despite the decline in COVID-19 severity. Per IMF, through 2023, inflation could remain stubbornly high, with continued labor market tightness and growing wage pressures requiring tighter monetary policies. On a brighter note, strengthening household balance sheets and wage growth are driving private demand. Overall, the Medical Instruments industry players are expected to collectively report a year-over-year decline in their revenues due to logistical challenges and increasing unit cost. This might get offset by an increase in essential and non-essential product demand by private households.

M&A Trend Continues: The medical instruments space has been benefiting from the ongoing merger and acquisition (M&A) trend. In fact, various reports suggest that M&A has been the key catalyst in the U.S. MedTech space of late. It is a known fact that smaller and mid-sized industry players attempt to compete with the big shots through consolidation. The big players attempt to enter new markets through a niche product. Among the significant deals of recent times, in December 2022, Johnson & Johnson completed the $16.6-billion mammoth acquisition of Abiomed. In February 2023, Abbott announced its plans to acquire Cardiovascular Systems, a medical device company with advanced atherectomy system used in treating peripheral and coronary artery disease. The same month, Globus Medical announced its plans to acquire the San-Diego based spine technology firm, NuVasive Inc., in an all-stock deal valued at around $3.1 billion.

Meanwhile, a MedTech Dive report of January 2023 revealed that MedTech players are expected to demonstrate a slow start to 2023 in terms on M&A. Yet, the experts say that despite higher interest rates and a volatile stock market, there are signs that strategic M&As are poised to rebound.

Digital Revolution: With an increase in the adoption of digital platforms within the medical device space, robotic surgeries, big-data analytics, bioprinting, 3D printing, electronic health records (EHR), predictive analytics, real-time alerting and revenue cycle management services are gaining prominence in the United States. A June 2019 Health care News report suggested that this market, valued at $123 billion in 2018, has been witnessing a CAGR of 25{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}. Various other reports suggest that companies that adopted AI witnessed a 50{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} reduction in treatment costs. Telemedicine stocks received an impressive response when, in 2021, the Centers for Disease Control and Prevention asked healthcare service communities to broaden the use of telemedicine.

Zacks Industry Rank Indicates Good Prospects

The Zacks Medical Instruments industry’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates encouraging near-term prospects. The industry, housed within the broader Zacks Medical sector, currently carries a Zacks Industry Rank #85, which places it in the top 34{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of more than 250 Zacks industries. Our research shows that the top 50{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the Zacks-ranked industries outperforms the bottom 50{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} by a factor of more than 2 to 1.

We will present a few stocks that have the potential to outperform the market based on a strong earnings outlook. But it’s worth taking a look at the industry’s shareholder returns and current valuation first.

Industry Underperforms S&P 500, Sector

The industry has underperformed the Zacks S&P 500 composite and its sector in the past year.

The industry has declined 9.5{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} compared with the S&P 500’s 6.9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} fall in a year’s time. The broader sector has declined 9.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in the said time frame.

One Year Price Performance

3 Medical Instruments Stocks to Buy Amid Improving Industry Trends

Industry’s Current Valuation

On the basis of the forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 33.06X compared with the broader industry’s 22.40X and the S&P 500’s 18.01X.

Over the past five years, the industry has traded as high as 45.08X, as low as 26.13X and at the median of 32.87X, as the charts show below.

Price-to-Earnings Forward Twelve Months (F12M)

Price-to-Earnings Forward Twelve Months (F12M)

3 Stocks to Buy Right Now

Hologic: Headquartered in Bedford, MA, Hologic develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products, which cater to the healthcare needs of women. Hologic has been making impressive progress in its Breast Health arm in recent times. The company is currently focusing on expanding its strategy to diversify business across the patient continuum of care. The company’s GYN Surgical business too has transformed to the most profitable division of Hologic on a percentage basis banking on new leadership, strong strategic execution of new commercial models and new product launches.
The consensus estimate for this Zacks Rank #1 (Strong Buy) company’s 2024 sales is pegged at $4.12 billion, indicating a 3.7{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} rise year over year.

The consensus mark for Hologic’s 2024 EPS is pegged at $3.99, indicating an increase of 7.6{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} from the year-ago period.

You can see the complete list of today’s Zacks #1 Rank stocks here. 

Price and Consensus: HOLX

 

Edwards Lifesciences: Headquartered in Irvine, CA, Edwards Lifesciences deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. Edwards Lifesciences expects to maintain its leadership position in the global Transcatheter Aortic Valve Replacement market through an increased focus on expanding patient access by actively leveraging current valve platforms for additional indications. This includes developing next-generation valve platforms, and maintaining trusted relationships with clinicians, payers and regulators. Edwards Lifesciences also remain committed to aggressively investing in structural heart disease and critical care technologies.

The Zacks Consensus Estimate for Edwards Lifesciences’ 2023 sales is pegged at $5.86 billion, indicating an 8.8{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} rise year over year. The same for Edwards Lifesciences’ adjusted earnings is pegged at $2.52 per share, an expected growth of 1.6{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} from 2022. Edwards Lifesciences carries a Zacks Rank #2 (Buy).

Price and Consensus: EW

IDEXX: Headquartered in Delaware, NJ, IDEXX is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company is deriving strong top-line growth driven by continued benefits from the expansion of IDEXX’s global premium instrument installed base. CAG Diagnostics’ organic recurring revenue growth reflects solid gains across IDEXX’s major modalities globally, supported by growth in clinical service demand and expanded utilization of diagnostic products and services.

The consensus estimate for this Zacks Rank #2 company’s 2023 sales is pegged at $3.64 billion, indicating an 8{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} rise year over year. The same for IDEXX’s 2023 earnings is pegged at $9.51, an expected 18.4{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} growth from the year-ago period.

Price and Consensus: IDXX

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Edwards Lifesciences Corporation (EW) : Free Stock Analysis Report

Hologic, Inc. (HOLX) : Free Stock Analysis Report

IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Who are the leading innovators in ultrasonic stimulation devices for the medical devices industry?

The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies, such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry. , according to GlobalData’s report on Innovation in Medical Devices: Ultrasonic stimulation devices.

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity. 

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have. 

150+ innovations will shape the medical devices industry 

According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry. 

Within the emerging innovation stage, neurostimulation therapy, smart physiotherapy devices, and real-time IR thermographic imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Precision radiotherapy, electric atomisers, and bio-active prosthesis coating are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bioresorbable stent coating and cryogenic tissue treatment, which are now well established in the industry. 

Innovation S-curve for the medical devices industry 

Who are the leading innovators in ultrasonic stimulation devices for the medical devices industry?

Ultrasonic stimulation device is a key innovation area in the medical devices industry 

Ultrasonic stimulation devices deliver non-invasive pulsed ultrasonic waves to specific areas in the brain to either inhibit or excite neural activity. The devices provide high spatial resolution and can potentially target different sites of the peripheral and central nervous system. It is an emerging therapeutic technique for an array of psychiatric, developmental and neurological disorders, gradually replacing the traditional electric and magnetic stimulation methods.  

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 40+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of ultrasonic stimulation devices. 

Key players in ultrasonic stimulation devices – a disruptive innovation in the medical devices industry  

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators. 

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. 

Medtronic is one of the leading patent filers in the field of ultrasonic stimulation devices. Some other key patent filers in the field include Merz Pharma and Highland Instruments. 

In terms of application diversity, Thermalin leads the pack, followed by Merz Pharma and Autonomix Medical. By means of geographic reach, Autonomix Medical holds the top position, followed by Medical Energetics and Cerevast Medical in the second and third spots, respectively. 

Ultrasonic stimulation devices have become crucial neuromodulation therapeutic tools for patients with brain disorders. The technology has drawn considerable attention for its advantages, such as deeper penetration and no tissue heating. The rapidly ageing population with brain disorders and limited availability of effective surgical and medication alternatives is likely to drive the overall growth of this market. 

To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices. 


Who are the leading innovators in robotic dental surgery tools for the medical devices industry?

The healthcare equipment field carries on to be a hotbed of innovation, with action pushed by greater need to have for homecare, preventative treatments, early diagnosis, lessening affected person recovery occasions and enhancing results, as very well as a developing worth of technologies these kinds of as device mastering, augmented reality, 5G and digitalisation. In the final three several years alone, there have been more than 450,000 patents submitted and granted in the clinical devices marketplace, in accordance to GlobalData’s report on Robotics in Clinical Devices: Robotic dental surgical procedure resources.

Having said that, not all improvements are equivalent and nor do they abide by a regular upward craze. In its place, their evolution requires the type of an S-shaped curve that displays their normal lifecycle from early emergence to accelerating adoption, just before ultimately stabilising and achieving maturity.

Figuring out in which a unique innovation is on this journey, specially those people that are in the emerging and accelerating stages, is essential for comprehending their current amount of adoption and the very likely foreseeable future trajectory and effect they will have.

150+ improvements will condition the healthcare products sector

In accordance to GlobalData’s Technologies Foresights, which plots the S-curve for the healthcare units market employing innovation depth products created on above 550,000 patents, there are 150+ innovation areas that will shape the upcoming of the business.

In the emerging innovation stage, HUDs for surgical navigation, robotic biopsy endoscope, and camera-guided surgical robots are disruptive technologies that are in the early phases of software and should be tracked closely. Robotic exoskeleton, surgical robots, and robotic catheters are some of the accelerating innovation parts, where by adoption has been steadily escalating. Among the maturing innovation areas are robotic reduced limb rehabilitation and microfluidic lab-on-a-chip, which are now properly founded in the field. 

Innovation S-curve for robotics in the clinical devices sector

Who are the leading innovators in robotic dental surgery tools for the medical devices industry?

Robotic dental operation instruments is a important innovation space in robotics

Robotic dental surgical procedures applications deliver a better quality of care as they supply elevated accuracy and precision, protection, streamlined work processes, and much better workflows when when compared with regular methods. As the dental markets mature and treatment prerequisites adjust, these robotic instruments are anticipated to become commonplace in the treatment method of compact and significant dental interventions.

GlobalData’s examination also uncovers the providers at the forefront of just about every innovation region and assesses the opportunity achieve and impact of their patenting action across various purposes and geographies.  According to GlobalData, there are 10+ firms, spanning technological innovation suppliers, set up health-related equipment organizations, and up-and-coming start-ups engaged in the enhancement and software of robotic dental surgery tools.

Essential gamers in robotic dental operation equipment – a disruptive innovation in the clinical devices field

‘Application diversity’ actions the quantity of distinct applications discovered for each individual pertinent patent and broadly splits providers into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the selection of unique nations around the world just about every suitable patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Neocis and Zimmer Biomet are top patent filers in the subject of robotics dental surgical treatment. Some other essential patent filers in the subject contain Navigate Surgical Systems and X-Nav Systems.

In phrases of software variety, Brain Navi Biotechnology prospects the pack, followed by Dental Monitoring and TROPHY. By signifies of geographic access, Mind Navi Biotechnology retains the major posture, adopted by Dentsply Sirona and Neocis in the next and third spots, respectively.

Though robotics in dentistry gives quite a few benefits, the future relies upon on the acceptance of the two dentists and people to use this know-how in each day apply. Also, additional innovations are required to make treatment method additional precise, available, and precise.

To additional fully grasp how robotics is disrupting the clinical equipment market, accessibility GlobalData’s newest thematic study report on Robotics in Professional medical (2021).


Are Gyms Failing or Thriving? Five Takeaways from “State of the Industry” Fitness Report

Are Gyms Failing or Thriving? Five Takeaways from “State of the Industry” Fitness Report

Photo Credit rating: CrossFit, LLC.

Experiencing Early morning Chalk Up? Accessibility added distinctive interviews, analyses, and stories with an Rx membership.

Considering the fact that its inception, CrossFit has developed to consider and meet up with the desires of athletes and maintain up with the at any time-transforming fitness tendencies. Even so, as most know, it can take a large amount to maintain a gymnasium afloat and several things come into perform when it arrives to all round achievement. Which is the place Two-Mind Business “State of the Industry” report arrives in. 

Two-Mind Business enterprise is a mentorship organization that operates to increase the accomplishment of gyms, together with CrossFit affiliate marketers. It also places out reviews periodically on how the business is fairing by employing their very own data with the addition of other sources like Wodify, TeamUp, and PushPress. In this third edition of the “State of the Industry” the corporation collected qualitative facts from Aug. 16 to Sept. 1, 2022 from 10,657 fitness centers all over the world.

As with any market it’s generally a good idea to acquire inventory of exactly where things stand and specifically for CrossFit affiliate marketers it can be handy to see the latest trends both equally favourable and detrimental in the exercise industry. 

Here are 5 vital takeaways from the report: 

  1. Promoting Programs Present Profitability: Out of the gyms surveyed 81{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of them operate advertisements, in accordance to the report. The most successful fitness centers had a internet marketing system typically with paid adverts and other funnels. The vast majority of these gyms have observed that they have to do a little something other than “waiting and hoping” to attain and retain associates. 

“This is a large enhancement from five years ago, when “marketing” was typically disregarded and often criticized,” claimed Chris Cooper, the operator of Two-Mind Organization, in the report. 

Which also observed on average CrossFit gyms obtained 22 leads for each month. And irrespective of how the gyms produced potential customers they all are “getting far better at attracting probable consumers to their internet site.” 

  1. Presenting Nutrition Coaching: Though many fitness centers offer private coaching, there’s been a substantially even bigger fascination, as of late, in nutrition coaching. So, it’s no surprise that CrossFit gyms topped all gyms, with 73{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} featuring the company.

“This is a excellent move forward even in 2016, when we started off submitting podcasts about nourishment coaching, much less than 10 p.c of all CrossFit gyms mentioned a independent company,” stated the report. 

On the flip aspect, even so, the nourishment company has not translated into a lot more earnings. A purpose for this may well be CrossFit and other gyms giving a hybrid membership that consists of nutrition and health and fitness coaching at 1 rate. 

“Gyms in all groups could take steps to maximize their nutrition income. On ordinary, all fitness centers generate just 5 per cent of revenue from nutrition coaching, and this range is down from 6.4 {bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in 2021. It is a distinct spot of opportunity,” said the report. 

For CrossFit exclusively, the report found just 4{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of income from diet coaching. This could be a potential location for significant profitability and a little something CrossFit gyms really should look at. 

  1. Average Retention is Way too Reduced: The sector ordinary size of engagement or LEG is 7.8 months, which the report states is considerably too minimal. Even though there isn’t a breakdown by gymnasium sort, the report includes some routines the most effective fitness centers provide. 
  1. They have a consultative method instead of a totally free demo course. 
  2. They make each and every customer a prescription that consists of a 1:1 on-ramp period but may differ in shipping immediately after the first 90 days. 
  3. They regularly keep track of customer development, update their prescriptions and display consumers the system for the up coming 90 times. 
  4. They persistently get success for shoppers and share their clients’ accomplishment stories. 

And last of all, the local community and lifestyle features are “present but not measurable.” 

4) Complete vs. Component-time Personnel: The report uncovered the normal quantity of total-time workers at a CrossFit fitness center is 1 and is element of an ongoing query for affiliate marketers as they make your mind up to provide on part or entire-time coaches. The report also found the regular quantity of part-time team at a CrossFit fitness center was 6. 

In September 2022, Early morning Chalk Up carried out a survey in an affiliate entrepreneurs forum inquiring health club entrepreneurs how many complete-time coaches they have, among other full-time staff members issues. 

The effects showed 113 out of 190 house owners claimed they did not have a one full-time mentor. And yet another 33 of the respondents mentioned they experienced just a person entire-time mentor. Industry experts in the field agreed that in order to have extensive-expression sustainability and profitability full-time personnel are critical. 

“There is surely a sweet location for the number of employees in a enterprise: as well couple and your staff members members get burned out and reduce electricity. Way too numerous and your group customers reduce alignment, occasionally with declines in high-quality of services,” explained the report. 

“In our study, the figures diversified extensively, from “I’m the only particular person doing work at my gym” to “we have 14 portion-time coaches executing 1-2 courses per week each and every.””

5)  CrossFit HQ Approval: The last number of years have brought about a ton of improve at CrossFit Inc. such as structural variations to the Game titles seasons in 2021 and 2022. In addition, top rated executive Eric Roza, the former Main Government Officer following Greg Glassman, stepped down from the place to board chairman. 

Irrespective of this and a lot of other newsworthy shake ups, 77{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of fitness center homeowners in the CrossFit classification now an affiliate approve of CrossFit Inc.’s path, in accordance to the report. 

“As a CrossFit aficionado, I enjoy tracking what HQ is accomplishing. With so significantly upheaval in the ecosystem around the final two several years, I wanted to get a authentic sense of how the affiliate local community feels about the brand name,” explained Cooper. 

Cooper adds, a 77 percent acceptance rating from affiliates “seems like a small score.” Having said that the determine is essentially slightly larger from 2021 when the approval score was 75 percent. 

The bottom line: There are a variety of components that appear into engage in when it will come to managing a successful affiliate, and sometimes it may well suggest altering your usual regimen and remaining open up to new strategies. 

A backlink to the complete report can be located here.

Get the Publication

For a every day digest of all points CrossFit. Local community, Competitions, Athletes, Suggestions, Recipes, Bargains and far more.

“*” suggests needed fields

Worldwide Micro Injection Molding Medical Devices Industry to 2027 – Players Include Biomerics, MTD Micro Molding, Kamek Precision Tools and PEXCO – ResearchAndMarkets.com

DUBLIN–(Company WIRE)–The “Micro Injection Molding Health-related Devices Market place – Progress, Tendencies, Covid-19 Influence, And Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s presenting.

The microinjection molding medical gadgets market is projected to document a CAGR of 7.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} above the forecast period of time (2022 – 2027).

Companies Described

  • Accu-Mold LLC
  • Biomerics
  • MTD Micro Molding
  • Micromolding Resolution Inc.
  • Kamek Precision Equipment
  • Sovrin Plastics
  • BMP Healthcare
  • Stamm AG
  • PEXCO
  • Makuta, Inc.

Essential Sector Tendencies

Endoscopic Products Segment Expects to Sign-up a High CAGR in the Forecast Period

The growing use of sophisticated micro parts for endoscopic surgery, the escalating desire for minimally invasive procedures, and the wish to offer extra comfort to sufferers with implants and health care equipment are driving marketplace progress in excess of the forecast time period.

The climbing prevalence of gastrointestinal disorders necessitating endoscopy surgeries and technical advancements in endoscopic gadgets are the crucial driving component for the market’s advancement. For occasion, in accordance to info published by the American Cancer Modern society (ACS), roughly 26,560 new cases of abdomen cancer are projected to be detected in the United States in 2021, with 16,160 males and 10,400 girls.

According to the data revealed by the National Middle for Biotechnology Facts in 2021, titled Innovative Endoscopic Imaging and Interventions in Gastroesophageal reflux condition (GERD): An Update and Future Directions, the prevalence of Gastroesophageal reflux illness (GERD) is approximated to be 18.1-27.8{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in North The us, 8.8-25.9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in Europe, and 2.5-7.8{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in East Asia.

Additionally, technological breakthroughs this sort of as fiberscopes and online video-aided endoscopes, as properly as elevating recognition of early condition prognosis and the gains of minimally invasive diagnostic techniques, are propelling the expansion of the endoscopic units section.

Hence, the raising recognition about minimally invasive surgical processes and the mounting prevalence of continual health conditions are boosting the market’s growth over the forecast interval.

North The united states is Envisioned to Have the Substantial Industry Share

The factors propelling the development of the microinjection molding clinical products market place are the significant adoption rate of medically highly developed procedures this sort of as minimally invasive surgical procedures and expanding consciousness about the minimally-invasive processes which get rid of the require to lower and distressing invasion.

The soaring prevalence of serious conditions these kinds of as cardiovascular diseases, cancer, and respiratory health conditions, which call for surgical procedures as procedure, is the key driving issue for market advancement. For occasion, according to GLOBOCAN, 2020, 2,281,658 new cancer conditions ended up identified in the United States in 2020, with 612,390 fatalities. Equally, according to the American Most cancers Society 2021, it is believed that 250 new situations of cervical most cancers will be diagnosed in 2021. According to stats released by the Canadian Most cancers Culture, in 2021, it is believed that 229,200 Canadians will be diagnosed with cancer, and 84,600 will die from most cancers.

In addition, the growing amount of cardiovascular ailments and surgery is most likely to raise the need for microinjection molded medical products in the sector as there is a substantial need for minimally-invasive strategies. In accordance to the information published by Philippine Studies Authority (PSA), 2020, it has been observed that ischaemic coronary heart disorders ended up the primary result in of dying from January to October 2021, with 110,332 cases or 18.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the whole fatalities in the place.

In accordance to the Earth Wellbeing Firm, 2021, an estimated 1,28 billion older people aged 30-79 years have coronary heart ailments, and approximately two-thirds of the populace lives in lower- or center-money international locations. The hazard of cardiovascular illness at the age of 24 is only 20{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, at the age of 45, it gets double to 50{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, and larger circumstances of cardiovascular health conditions are seen in men and women over the age of 60 years.

Moreover, the climbing variety of listening to difficulties among individuals improves the demand for hearing aids which further will increase the desire for micro-molding health-related gadgets in the region, as the firms are generating listening to aids utilizing micro-molding techniques. For instance, in accordance to the Facilities for Illness Control, in 2021, it is approximated that about 16{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of grown ups have some listening to troubles, and 11{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the persons documented tinnitus or ringing in the ear.

Important Matters Covered:

1 INTRODUCTION

2 Research METHODOLOGY

3 Government SUMMARY

4 Market place DYNAMICS

4.1 Market place Overview

4.2 Current market Drivers

4.2.1 Increasing Adoption of Minimally Invasive Methods

4.2.2 Growing Adoption of Miniaturization and Nanotechnology

4.3 Sector Restraints

4.3.1 Higher Expense Connected with Micro Injection Molding Machines

4.4 Porter’s Five Forces Examination

5 Marketplace SEGMENTATION

5.1 By Materials Style

5.2 By Application

5.3 Geography

6 Competitive LANDSCAPE

6.1 Firm Profiles

7 Marketplace Options AND Future Tendencies

For a lot more information and facts about this report visit https://www.researchandmarkets.com/r/v7t2kj

Worldwide Medical Devices Contract Research Organizations Industry to 2035

DUBLIN, Dec. 28, 2022 /PRNewswire/ — The “Medical Devices Contract Research Organizations Market by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered, and Key Geographies: Industry Trends and Global Forecasts, 2022-2035” report has been added to  ResearchAndMarkets.com’s offering.

Worldwide Medical Devices Contract Research Organizations Industry to 2035

Research and Markets Logo

This report features an extensive study of the current market landscape and future opportunities associated with the medical device contract research organizations market. The study also includes an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

According to the World Health Organization (WHO), presently, around two million medical devices are available across the globe. Further, just over 35 medical devices received approval by the USFDA, every year. It is worth highlighting that, since 2020, the USFDA has approved around 105 medical devices.

Moreover, the medical devices are expected to capture more than 40{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the global medtech industry and this value is projected to grow at a steady pace over the coming years. In this context, the number of medical device focused clinical trials have increased at a considerable rate, over the past few years.

However, only a few players engaged in this domain claim to have the technical expertise to carry out in-house clinical research. This can be attributed to the high costs associated with acquiring the required infrastructure and capabilities to carry out research in this domain.

In addition, various regulatory guidelines render medical devices subject to rigorous quality assessments, thereby, making it difficult for firms with limited finances to undertake research initiatives. Specifically, post the onset of the COVID-19 pandemic, there has been a substantial increase in the demand for medical devices as they have the ability to enable early diagnosis, as well as provide non-invasive and effective treatments.

Given the surge in demand for medical devices in the recent past, coupled to the aforementioned constraints faced by developers, a large number of small, as well as well-established, players prefer to outsource a significant share of their respective clinical operations and regulatory affairs management to contract research organizations (CROs). Since 2010, over 75 CROs have been established in this domain.

Further, in order to support the growing demand, medical device CROs have been re-evaluating and bolstering their existing capabilities to offer a wide range of services to their clients. Integration of novel technologies and tools, such as cloud computing, risk monitoring tools, real-world evidence and advanced data analytics, is another key initiative being undertaken by several CROs to distinguish themselves from their competitors.

To enable expansion of their existing capabilities, more than 55 acquisitions and / or strategic alliances have been established by service providers in this market, since 2015. Considering the prevalent trends and projected opportunity associated with the overall medical devices market, we believe that the medical devices CROs market is likely to witness consistent grow, till 2035.

The report features detailed transcripts of interviews held with the following stakeholders:

  • Lajos Sarosi (Chief Executive Officer and Co-founder, HungaroTrial)

  • Lee King (Senior Vice President, Business Development and Marketing)

  • Christopher Rupp (Vice President of Global Marketing and Commercial Operations, NAMSA)

  • Claus Hemiker (Head, Business Development)

  • Christian Wolflehner (General Manager, CW Research & Management)

  • Troy W. Mccall (Chief Commercial Officer, CROMSOURCE)

  • Nazish Urooj (Senior manager, Medical & Clinical Operations, Metrics Research)

  • C. Omprakash (Technical Director and Partner, Vyomus Consulting)

  • Tania Persson (Director of Business Development, A+ Science)

  • Alexa Foltin-Mertgen (Business Development Manager, AtoZ-CRO)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the key players engaged in offering contract research services for medical devices?

  • Which regions represent the key contract research hubs for medical devices?

  • What are the key regulatory guidelines, related to medical devices that have been established across various geographies?

  • What are the key value drivers of the merger and acquisition activity observed within this domain?

  • What percentage of the medical devices research operations are presently outsourced?

  • What are the likely future trends in contract research services market for medical devices?

  • How is the current and future opportunity likely to be distributed across key market segments?

  • What is the total cost of ownership required to set up a medical device contract research organization?

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Medical Devices
3.2.1. Historical Evolution of Medical Devices
3.2.2. Classification of Medical Devices
3.3. Overview of Contract Research Organizations (CROs)
3.3.1. Evolution of CROs
3.4. Role of CROs in the Medical Device Industry
3.5. Types of Medical Device CROs
3.6. Types of Services Offered by CROs
3.7. Advantages of Outsourcing Operations to CROs
3.8. Risks and Challenges Associated with Outsourcing
3.9. Key Considerations While Selecting a Suitable CRO Partner

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Medical Device CROs: Clinical Service Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Area of Specialization
4.2.6. Analysis by Device Class
4.2.7. Analysis by Type of Clinical Operation Service Offered
4.2.8. Analysis by Type of Regulatory Affairs-related Service Offered
4.2.9. Analysis by Type of Additional Service Offered
4.2.10. Analysis by Medical Device Regulatory Compliance Authority
4.3. Medical Device CROs: Preclinical Service Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Company Size and Location of Headquarters
4.3.5. Analysis by Type of Preclinical Service Offered
4.4. Medical Device CROs: Standalone Service Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Company Size and Location of Headquarters

5. REGULATORY AND REIMBURSEMENT LANDSCAPE FOR MEDICAL DEVICES
5.1. Chapter Overview
5.2. General Regulatory and Reimbursement Guidelines for Medical Devices
5.3. Regulatory and Reimbursement Landscape in North America
5.4. Regulatory and Reimbursement Landscape in Europe
5.5. Regulatory and Reimbursement Landscape in Asia-Pacific and Rest of the World
5.6. Comparison of Regional Regulatory Control
5.7. Concluding Remarks

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Avania (Formerly known as Factory CRO)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Charles River Laboratories
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. CROMSOURCE
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. CSSi LifeSciences
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Eurofins Medical Device Testing
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. IQVIA
6.7.1. Company Overview
6.7.2. Service Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Medpace
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. NAMSA
6.9.1. Company Overview
6.9.2. Service Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Qserve Group
6.10.1. Company Overview
6.10.2. Service Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. WuXi AppTec
6.11.1. Company Overview
6.11.2. Service Portfolio
6.11.3. Recent Developments and Future Outlook

7. MEDICAL DEVICE DEVELOPER AND CRO RELATIONSHIPS: KEY VALUE DRIVERS AND PERFORMANCE INDICATORS
7.1. Chapter Overview
7.2. Definition and Importance of Key Performance Indicators (KPIs)
7.3. Key Considerations for Selection of KPIs
7.4. Types of KPIs
7.5. Comparison of Key Performance Indicators
7.6. Concluding Remarks

8. COMPETITIVE BENCHMARKING
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Competitive Benchmarking by Region
8.4. Concluding Remarks

9. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Brand Positioning Matrix: Labcorp
9.4. Brand Positioning Matrix: IQVIA
9.5. Brand Positioning Matrix: Syneos Health
9.6. Brand Positioning Matrix: PPD
9.7. Brand Positioning Matrix: ICON
9.8. Brand Positioning Matrix: Charles River Laboratories
9.9. Brand Positioning Matrix: WuXi AppTec
9.10. Brand Positioning Matrix: Medpace

10. CLINICAL TRIAL ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Medical Devices: Clinical Trial Analysis
10.4. Medical Devices: Analysis by Enrolled Patient Population

11. MERGERS AND ACQUISITIONS
11.1. Chapter Overview
11.2. Merger and Acquisition Models
11.3. Medical Device CROs: Mergers and Acquisitions

12. TOTAL COST OF OWNERSHIP IN MEDICAL DEVICES CONTRACT RESEARCH ORGANIZATION
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Expenditures Incurred by a Medical Device Contract Research Organization
12.4. Total Cost of Ownership of Medical Devices Contract Research Organizations, 2022-2042
12.5. Total Cost of Ownership of Medical Devices Contract Research Organizations: Analysis by CAPEX and OPEX Costs, 2022 and 2042
12.6. Concluding Remarks

13. SURVEY INSIGHTS
13.1. Chapter Overview
13.2. Designation of Respondents
13.3. Types of Services Offered
13.4. Target Therapeutic Area
13.5. Average Number of Annual Projects
13.6. Market Opportunity

14. MARKET SIZING AND OPPORTUNITY ANALYSIS

15. SWOT ANALYSIS

16. FUTURE TRENDS AND OPPORTUNITIES

17. INTERVIEW TRANSCRIPTS

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/6jr6c5

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/worldwide-medical-devices-contract-research-organizations-industry-to-2035—current-market-landscape-and-future-opportunities-301710531.html

SOURCE Research and Markets